Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 27, 2018
[ Tue, Feb 27th 2018
] - WOPRAI
[ Tue, Feb 27th 2018
] - WOPRAI
[ Tue, Feb 27th 2018
] - WOPRAI
[ Tue, Feb 27th 2018
] - WOPRAI
[ Tue, Feb 27th 2018
] - WOPRAI
[ Tue, Feb 27th 2018
] - WOPRAI
[ Tue, Feb 27th 2018
] - WOPRAI
[ Tue, Feb 27th 2018
] - WOPRAI
Mon, February 26, 2018
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
Matthew Harrison Maintained (BLUE) at Hold with Increased Target to $152 on, Feb 26th, 2018
Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Increased Target from $151 to $152 on, Feb 26th, 2018.
Matthew has made no other calls on BLUE in the last 4 months.
There are 10 other peers that have a rating on BLUE. Out of the 10 peers that are also analyzing BLUE, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ying Huang of "B of A Securities" Maintained at Hold with Increased Target to $218 on, Thursday, February 22nd, 2018
- Michael Schmidt of "Leerink Swann" Downgraded from Buy to Hold on, Thursday, January 25th, 2018
- Mark Breidenbach of "Oppenheimer" Initiated at Hold on, Thursday, December 21st, 2017
- Jason McCarthy of "Maxim Group" Downgraded from Strong Buy to Hold on, Wednesday, December 13th, 2017
- Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, November 6th, 2017
These are the ratings of the 5 analyists that currently disagree with Matthew
- Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $222 on, Thursday, February 22nd, 2018
- Biren Amin of "Jefferies" Upgraded from Hold to Strong Buy on, Monday, December 11th, 2017
- John Newman of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $202 on, Tuesday, December 5th, 2017
- Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
